YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
109 hedge funds and large institutions have $920M invested in Y-mAbs Therapeutics in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
3.04% more ownership
Funds ownership: 50.49% → 53.53% (+3%)
Holders
109
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$26.2M | |
| 2 | +$14.3M | |
| 3 | +$7.22M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.83M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$5.4M |
Top Sellers
| 1 | -$18M | |
| 2 | -$7.22M | |
| 3 | -$6.8M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.78M |
| 5 |
AG
Artal Group
Luxembourg
|
-$4.32M |